Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

111 drug samples tested in November found ‘not of standard quality’

by AIP Online Bureau | Dec 28, 2024 | Health, Regulation, Risk Management

Besides, 70 drug samples tested by the state drugs testing laboratories have also been identified as NSQ in November, they official sources said New Delhi: Central Drugs Standard Control Organisation (CDSCO) has found 41 drug samples tested in the central drug...

Govt asks manufacturers to cut price of 3 anti-cancer drugs

by AIP Online Bureau | Oct 29, 2024 | Eco/Invest/Demography, Health, Indian News, Policy, Regulation

In line with the government’s commitment to ensure the availability of drugs at affordable prices, the National Pharmaceutical Pricing Authority (NPPA) has issued an office memorandum directing the concerned manufacturers to reduce the MRP on three anti-cancer...

Weight-Loss drugs estimated to save airlines millions

by AIP Online Bureau | Sep 30, 2023 | Eco/Invest/Demography, Health, International News

Weight is a major concern for airlines because the more a plane weighs, the more fuel it burns. Fuel and labor are the two largest expenses for carriers, with fuel accounting for about 25%. Over the years airlines have used a variety of methods to reduce pounds on...

Govt bans 14 fixed dose combination drugs, cites they may involve risk to people

by AIP Online Bureau | Jun 4, 2023 | Health, Indian News, Policy, Regulation

The banned drugs included those used for treating common infections, cough, and fever — combinations such as Nimesulide + Paracetamol dispersible tablets, Chlorpheniramine Maleate + Codeine Syrup, Pholcodine +Promethazine, Amoxicillin + Bromhexine and Bromhexine...

Centre considering testing drugs at govt laboratories before exporting

by AIP Online Bureau | May 20, 2023 | Health, Indian News, Regulation, Risk Management

“The CDSCO has submitted that some intervention from the government was necessary to stop the low-quality cough syrups from entering the global supply chain from India,” an official said New Delhi: Amid quality issues being raised globally for the cough...
« Older Entries

Recent Posts

  • Families of 737 MAX crash victims to object to deal allowing Boeing to avoid prosecution
  • Kin of accident victim get Rs 41 lakh compensation MACT overrules cheque dishonoured argument
  • Obesity silent tsunami of India’s disease burden, say experts
  • Delhi gets its first brain health clinic; 10 more planned across city
  • Foreign investors infuse Rs 4,452 cr in Indian equities this week, net investment in May at Rs 18,620 cr: NSDL

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy